Iovance Biotherapeutics Statistics
Total Valuation
IOVA has a market cap or net worth of $1.16 billion. The enterprise value is $888.61 million.
Important Dates
The next estimated earnings date is Thursday, May 8, 2025, after market close.
| Earnings Date | May 8, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
IOVA has 327.88 million shares outstanding. The number of shares has increased by 23.28% in one year.
| Current Share Class | 327.88M |
| Shares Outstanding | 327.88M |
| Shares Change (YoY) | +23.28% |
| Shares Change (QoQ) | +0.53% |
| Owned by Insiders (%) | 8.99% |
| Owned by Institutions (%) | 60.54% |
| Float | 251.87M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 6.22 |
| Forward PS | 2.49 |
| PB Ratio | 1.51 |
| P/TBV Ratio | 2.70 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 5.42 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 3.74, with a Debt / Equity ratio of 0.08.
| Current Ratio | 3.74 |
| Quick Ratio | 3.21 |
| Debt / Equity | 0.08 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -57.48% and return on invested capital (ROIC) is -34.57%.
| Return on Equity (ROE) | -57.48% |
| Return on Assets (ROA) | -29.22% |
| Return on Invested Capital (ROIC) | -34.57% |
| Return on Capital Employed (ROCE) | -50.16% |
| Revenue Per Employee | $195,788 |
| Profits Per Employee | -$444,125 |
| Employee Count | 838 |
| Asset Turnover | 0.19 |
| Inventory Turnover | 4.01 |
Taxes
| Income Tax | -2.83M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -76.10% in the last 52 weeks. The beta is 0.93, so IOVA's price volatility has been similar to the market average.
| Beta (5Y) | 0.93 |
| 52-Week Price Change | -76.10% |
| 50-Day Moving Average | 5.56 |
| 200-Day Moving Average | 8.31 |
| Relative Strength Index (RSI) | 22.83 |
| Average Volume (20 Days) | 11,449,512 |
Short Selling Information
The latest short interest is 63.60 million, so 19.40% of the outstanding shares have been sold short.
| Short Interest | 63.60M |
| Short Previous Month | 63.91M |
| Short % of Shares Out | 19.40% |
| Short % of Float | 25.25% |
| Short Ratio (days to cover) | 6.16 |
Income Statement
In the last 12 months, IOVA had revenue of $164.07 million and -$372.18 million in losses. Loss per share was -$1.28.
| Revenue | 164.07M |
| Gross Profit | 40.08M |
| Operating Income | -395.28M |
| Pretax Income | n/a |
| Net Income | -372.18M |
| EBITDA | -362.11M |
| EBIT | -395.28M |
| Loss Per Share | -$1.28 |
Full Income StatementBalance Sheet
The company has $323.78 million in cash and $58.26 million in debt, giving a net cash position of $265.52 million or $0.81 per share.
| Cash & Cash Equivalents | 323.78M |
| Total Debt | 58.26M |
| Net Cash | 265.52M |
| Net Cash Per Share | $0.81 |
| Equity (Book Value) | 710.41M |
| Book Value Per Share | 2.33 |
| Working Capital | 334.68M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$352.98 million and capital expenditures -$11.07 million, giving a free cash flow of -$364.05 million.
| Operating Cash Flow | -352.98M |
| Capital Expenditures | -11.07M |
| Free Cash Flow | -364.05M |
| FCF Per Share | -$1.11 |
Full Cash Flow StatementMargins
Gross margin is 24.43%, with operating and profit margins of -240.92% and -226.84%.
| Gross Margin | 24.43% |
| Operating Margin | -240.92% |
| Pretax Margin | -228.56% |
| Profit Margin | -226.84% |
| EBITDA Margin | -220.70% |
| EBIT Margin | -240.92% |
| FCF Margin | n/a |
Dividends & Yields
IOVA does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -23.28% |
| Shareholder Yield | -23.28% |
| Earnings Yield | -32.25% |
| FCF Yield | -31.54% |
Dividend DetailsAnalyst Forecast
The average price target for IOVA is $20.25, which is 472.84% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $20.25 |
| Price Target Difference | 472.84% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 8 |
| Revenue Growth Forecast (5Y) | 54.28% |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsStock Splits
The last stock split was on September 26, 2013. It was a reverse split with a ratio of 0.01:1.
| Last Split Date | Sep 26, 2013 |
| Split Type | Reverse |
| Split Ratio | 0.01:1 |
Scores
IOVA has an Altman Z-Score of 4.33 and a Piotroski F-Score of 4.
| Altman Z-Score | 4.33 |
| Piotroski F-Score | 4 |